These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 38348517

  • 1. Atrial fibrillation and risk of adverse outcomes in heart failure with reduced, mildly reduced, and preserved ejection fraction: A systematic review and meta-analysis.
    Kroshian G, Joseph J, Kinlay S, Peralta AO, Hoffmeister PS, Singh JP, Yuyun MF.
    J Cardiovasc Electrophysiol; 2024 Apr; 35(4):715-726. PubMed ID: 38348517
    [Abstract] [Full Text] [Related]

  • 2. Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.
    Sartipy U, Dahlström U, Fu M, Lund LH.
    JACC Heart Fail; 2017 Aug; 5(8):565-574. PubMed ID: 28711451
    [Abstract] [Full Text] [Related]

  • 3. Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction.
    Son MK, Park JJ, Lim NK, Kim WH, Choi DJ.
    Heart; 2020 Aug; 106(15):1160-1168. PubMed ID: 32341140
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prevalence and Prognostic Implication of Atrial Fibrillation in Heart Failure Subtypes: Systematic Review and Meta-Analysis.
    Mundisugih J, Franke KB, Tully PJ, Munawar DA, Kumar S, Mahajan R.
    Heart Lung Circ; 2023 Jun; 32(6):666-677. PubMed ID: 37003940
    [Abstract] [Full Text] [Related]

  • 7. Dronedarone for the treatment of atrial fibrillation with concomitant heart failure with preserved and mildly reduced ejection fraction: a post-hoc analysis of the ATHENA trial.
    Vaduganathan M, Piccini JP, Camm AJ, Crijns HJGM, Anker SD, Butler J, Stewart J, Braceras R, Albuquerque APA, Wieloch M, Hohnloser SH.
    Eur J Heart Fail; 2022 Jun; 24(6):1094-1101. PubMed ID: 35293087
    [Abstract] [Full Text] [Related]

  • 8. Systematic review and meta-analysis of stroke and thromboembolism risk in atrial fibrillation with preserved vs. reduced ejection fraction heart failure.
    Zhang M, Zhou J.
    BMC Cardiovasc Disord; 2024 Sep 18; 24(1):495. PubMed ID: 39289613
    [Abstract] [Full Text] [Related]

  • 9. Heart failure progression and mortality in atrial fibrillation patients with preserved or reduced left ventricular ejection fraction.
    Slee A, Saad M, Saksena S.
    J Interv Card Electrophysiol; 2019 Sep 18; 55(3):325-331. PubMed ID: 30887281
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prognostic Significance of New-Onset Atrial Fibrillation in Heart Failure with Preserved, Mid-Range, and Reduced Ejection Fraction Following Acute Myocardial Infarction: Data from the NOAFCAMI-SH Registry.
    Hao C, Luo J, Liu B, Xu W, Li Z, Gong M, Qin X, Shi B, Wei Y.
    Clin Interv Aging; 2022 Sep 18; 17():479-493. PubMed ID: 35444413
    [Abstract] [Full Text] [Related]

  • 12. Thromboembolisms in atrial fibrillation and heart failure patients with a preserved ejection fraction (HFpEF) compared to those with a reduced ejection fraction (HFrEF).
    Sobue Y, Watanabe E, Lip GYH, Koshikawa M, Ichikawa T, Kawai M, Harada M, Inamasu J, Ozaki Y.
    Heart Vessels; 2018 Apr 18; 33(4):403-412. PubMed ID: 29067492
    [Abstract] [Full Text] [Related]

  • 13. Association between atrial fibrillation and heart failure with different ejection fraction categories and its influence on outcomes.
    Xu HX, Zhu YM, Hua Y, Huang YH, Lu Q.
    Acta Cardiol; 2020 Sep 18; 75(5):423-432. PubMed ID: 31141463
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prevalence and outcomes of heart failure phenotypes in patients with atrial fibrillation.
    Tersalvi G, Bossard M, Aeschbacher S, Wiencierz A, Beer JH, Rodondi N, Gencer BF, Reichlin T, Auricchio A, Ammann P, Moschovitis G, Bonati L, Osswald S, Kühne M, Conen D, Kobza R.
    Int J Cardiol; 2024 Oct 01; 412():132320. PubMed ID: 38964549
    [Abstract] [Full Text] [Related]

  • 16. Five-year mortality of heart failure with preserved, mildly reduced, and reduced ejection fraction in a 4880 Chinese cohort.
    Chen S, Huang Z, Liang Y, Zhao X, Aobuliksimu X, Wang B, He Y, Kang Y, Huang H, Li Q, Yao Y, Lu X, Qian X, Xie X, Liu J, Liu Y.
    ESC Heart Fail; 2022 Aug 01; 9(4):2336-2347. PubMed ID: 35437939
    [Abstract] [Full Text] [Related]

  • 17. Both HFpEF and HFmrEF should be included in calculating CHA2DS2-VASc score: A Taiwanese longitudinal cohort.
    Cheng CC, Huang PS, Chen JJ, Chiu FC, Chang SN, Wang YC, Wu CK, Hwang JJ, Tsai CT.
    Heart Rhythm; 2024 Sep 01; 21(9):1500-1506. PubMed ID: 38423377
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prevalence and Prognostic Implications of Longitudinal Ejection Fraction Change in Heart Failure.
    Savarese G, Vedin O, D'Amario D, Uijl A, Dahlström U, Rosano G, Lam CSP, Lund LH.
    JACC Heart Fail; 2019 Apr 01; 7(4):306-317. PubMed ID: 30852236
    [Abstract] [Full Text] [Related]

  • 20. Characteristics and long-term prognosis of patients with reduced, mid-range, and preserved ejection fraction: A systemic review and meta-analysis.
    Liang M, Bian B, Yang Q.
    Clin Cardiol; 2022 Jan 01; 45(1):5-17. PubMed ID: 35043472
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.